Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank8
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-77.51M
↓ 115% vs avg
Percentile
P8
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-36.06M
Historical baseline
PeriodValueYoY Change
TTM$-77.51M-13.4%
2024$-68.34M-193.5%
2023$-23.29M+37.5%
2022$-37.27M+53.7%
2021$-80.48M-77.1%
2020$-45.45M-236.4%
2019$-13.51M-3.4%
2018$-13.07M-191.1%
2017$14.35M+189.4%
2016$-16.05M-